News Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Real-time Estimate Cboe BZX Other stock markets 01:17:51 2024-05-07 pm EDT			5-day change	1st Jan Change
2.515 ^USD	+18.63%		+20.81%	-20.40%

02:58pm	Investor Sentiment Muted After Rate Cut Optimism, Stifling US Equity Futures Pre-Bell	MT
02:01pm	Top Premarket Gainers	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Investor Sentiment Muted After Rate Cut Optimism, Stifling US Equity Futures Pre-Bell	08:58am	MT
Top Premarket Gainers	08:01am	MT
Transcript : Esperion Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024	08:00am
Esperion Therapeutics: Q1 Earnings Snapshot	06:12am	AQ
Earnings Flash (ESPR) ESPERION THERAPEUTICS Posts Q1 Revenue $137.7M, vs. Street Est of $83.9M	06:11am	MT
Earnings Flash (ESPR) ESPERION THERAPEUTICS Posts Q1 EPS $0.34, vs. Street Est of $-0.01	06:11am	MT
Esperion Reports First Quarter 2024 Financial Results	06:00am	GL
Esperion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06:00am	CI
Esperion to Participate in Upcoming May Investor Conferences	Apr. 29	GL
Esperion to Report First Quarter 2024 Financial Results on May 7	Apr. 23	GL
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL Tablets in Diverse Populations Including Women, Hispanics, Latinx and Patients with Obesity	Apr. 08	AQ
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity	Apr. 07	AQ
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity	Apr. 07	GL
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024	Apr. 01	GL
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session and Industry Expert Theatre to be presented at ACC.24	Mar. 26	AQ
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference	Mar. 26	GL
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24	Mar. 25	GL
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24	Mar. 25	AQ
Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol	Mar. 25	DJ
Sector Update: Health Care Stocks Steady Premarket Monday	Mar. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Summary

Filters